Telix Pharmaceuticals
在场
是其中之一......
Telix Pharmaceuticals 是一家在股票代码 TLX (AU) 下上市的公司。
Telix Pharmaceuticals 在 3 个国家有直接业务。Telix Pharmaceuticals 拥有 3家子公司，其中包括 Telix Pharmaceuticals Americas、Telix Pharmaceuticals APAC 和 Telix Pharmaceuticals EMEA。
高管
查看带有其 35 名主要高管的组织结构图
Telix Pharmaceuticals 搜索最多的简介
- Christian Behrenbruch, Director, Group Managing Director and Chief...
- Mark Nelson, Non-Executive Director
- Kevin McCann, Independent, Non-Executive Chairman (retiring on May...
高管在Telix Pharmaceuticals变化
- Tiffany Olson 曾任 Independent Non-Executive Director, 将于 20255月21 升职为 Chairman of the Board (新闻发布的2025二月27号).
- Marie McdonaldMarie Mcdonald 将于20253月3作为 Director 加入公司 (新闻发布的2025二月27号).
- Kevin McCann, Independent, Non-Executive Chairman, 将于 20255月21 退休 (新闻发布的2025二月27号).
创建提醒
跟踪 Telix Pharmaceuticals 的高管变动
药店
Telix Pharmaceuticals 拥有 1,833 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Roche (瑞士)。
Popular M&A news in 药店
- Knight Therapeutics has announced the acquisition of Paladin Labs (公布2025三月12号).
- Jazz Pharmaceuticals 已收购 Chimerix (公布2025三月6号).
- Cosette Pharmaceuticals has announced the acquisition of Mayne Pharma (公布2025二月25号).
药店 行业的其他推荐联系人
消息
Telix Pharmaceuticals 的最新新闻稿
- Investor webinar: Telix Therapeutics Urology Showcase and Expert Forum | Telix Pharmaceuticals
- Patients Risk Missing Out on Revolution in Cancer Treatment: Report | Telix Pharmaceuticals
- Illuccix® Approved in Norway | Telix Pharmaceuticals
- Illuccix® Approved in the United Kingdom | Telix Pharmaceuticals
- Illuccix® Approved in Denmark | Telix Pharmaceuticals
- Telix Full Year Results 2024 Investor Webcast Notification | Telix Pharmaceuticals
- Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025) | Telix Pharmaceuticals
- Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion | Telix Pharmaceuticals
- Statement on impact of U.S. tariffs | Telix Pharmaceuticals
- Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform | Telix Pharmaceuticals
- View more press releases Close
